Thrombin-activatable fibrinolysis inhibitor (TAFI) exhibits anti-fibrinolytic activity by removing C-terminal lysine residues from fibrin or plasminogen receptor proteins on the cellular surface, and plays an important role in the regulation of fibrinolysis. In this study, we examined the regulation of TAFI in hepatocytes during liver regeneration, and revealed its pivotal role in hepatocyte proliferation. In rat models, partial hepatectomy or carbon tetrachloride (CCl 4 )-induced acute liver injury suppressed the levels of plasma TAFI activity and hepatic TAFI mRNA, whereas this operation markedly increased both the hepatic plasmin activity and the level of proliferating cell nuclear antigen. In primary cultures of rat hepatocytes, the TAFI mRNA level was decreased under growth-promoting culture conditions. Treatment of the hepatocytes with TAFI siRNA increased the amount of plasmin on the hepatocytes and promoted hepatocyte proliferation. We concluded that TAFI regulates plasmin activity through its enzymatic activity whereby it reduces the plasminogen-binding capacity of the hepatocytes. The TAFI gene expression is down-regulated in hepatocyte proliferation for producing a fibrinolytic microenvironment suitable for cell growth. This is the first report on the role of TAFI in the pericellular fibrinolysis necessary for cellular proliferation.
Thrombin-activatable fibrinolysis inhibitor (TAFI)3 is a 60-kDa plasma glycoprotein secreted by hepatocytes as an inactive form. Activation of TAFI is known to be mediated by thrombin (1), thrombin-thrombomodulin complex (2), or plasmin (3). Activated TAFI down-regulates fibrinolysis by removing the plasminogen-anchoring structure from fibrin. This fibrin structure contains C-terminal lysine residues, to which plasminogen binds via its lysine-binding site (4). Thus, TAFI is thought to exhibit negative regulatory activity in the binding of plasminogen to fibrin or cell surfaces.It is well known that plasminogen on fibrin or a cell surface exerts its maximum activity there, because this binding is not only a prerequisite for plasminogen activators to convert plasminogen to plasmin efficiently, but also a guarantee for the plasmin to be protected from inactivation by specific inhibitors, such as ␣2-plasmin inhibitor (5). As such, plasminogen can fulfill its roles for both thrombolysis and pericellular proteolysis, when it is located on the surface (6).It has been reported that activation of plasminogen is observed at the early stage of liver regeneration in rats and that plasmin contributes to the priming of hepatocytes for proliferation through the reorganization of extracellular matrix (ECM) components (7). The impairment of liver regeneration and abnormalities in liver repair have been observed in plasminogen-deficient mice, when they have undergone partial hepatectomy (8, 9) or been treated with CCl 4 (10). We demonstrated that the plasminogen activator/plasmin system acts to enhance the formation of hepatocyte spheroids (11) and to promote the proliferation of hepatocyt...